Brown, University of Cape Town partner to create next generation of HIV social science in South Africa

The public health schools at Brown University and the University of Cape Town have launched a new research and training partnership to create "the next generation of HIV social science in South Africa." The Eunice Kennedy Shriver National Institute of Child Health and Human Development is funding the collaboration with a new $1.9 million, five-year grant.

South Africa has the largest HIV-positive population in the world, with 6.2 million people - nearly one in six adults - living with the virus.

Brown public health Professor Mark Lurie said the partnership will aim to develop a cadre of rigorously trained social scientists who have the capability to devise sustainable approaches to guide South Africa's response to the epidemic.

The partnership will conduct student exchange programs, develop curriculum, advance and strengthen teaching methods, and promote research in areas such as Gender in HIV/AIDS risk and response, antiretroviral therapy adherence and expansion, and prevention for women, youth and families.

"This new grant is a wonderful opportunity for Brown to contribute in meaningful ways to the training of the next generation of South African social scientists whose work is aimed at better understanding and preventing HIV infection in the very country with the most severe epidemic," said Lurie, a native of South Africa who has studied sub-Saharan Africa's HIV epidemic for more than a decade. "There are funds available for advanced graduate students and junior faculty at both institutions to participate in research collaborations, as well as funds for student and faculty exchanges via mini-sabbaticals."

Lurie will lead Brown's participation. Chris Colvin, Senior Research Officer in Social Sciences and HIV/AIDS, TB and STIs, is the partnership's co-leader at the Centre for Infectious Disease Epidemiology and Research at the University of Cape Town.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Affordability and supply remain critical to the success of long-lasting HIV drug